Cargando…
MicroRNA‐708‐3p mediates metastasis and chemoresistance through inhibition of epithelial‐to‐mesenchymal transition in breast cancer
Metastasis and chemoresistance remain major challenges in the clinical treatment of breast cancer. Recent studies show that dysregulated microRNAs (miRNAs) play an important role in metastasis and chemoresistance development in breast cancer. Herein, we identified downregulated expression of miR‐708...
Autores principales: | Lee, Jin‐Won, Guan, Wei, Han, Sanghak, Hong, Deok‐Ki, Kim, Lee‐Su, Kim, Haesung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980212/ https://www.ncbi.nlm.nih.gov/pubmed/29575368 http://dx.doi.org/10.1111/cas.13588 |
Ejemplares similares
-
Epithelial-Mesenchymal Transition and MicroRNAs in Colorectal Cancer Chemoresistance to FOLFOX
por: Escalante, Paula I., et al.
Publicado: (2021) -
Silencing of microRNA-708 promotes cell growth and epithelial-to-mesenchymal transition by activating the SPHK2/AKT/β-catenin pathway in glioma
por: Chen, Yan, et al.
Publicado: (2019) -
MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT)
por: Ding, Xiang-Ming
Publicado: (2014) -
Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives
por: Díaz-López, Antonio, et al.
Publicado: (2014) -
Effects of metformin and phenformin on apoptosis and epithelial‐mesenchymal transition in chemoresistant rectal cancer
por: Park, Ji‐Hye, et al.
Publicado: (2019)